[Retracted] Upregulating hsa-miR-128a Increased the Effects of Pembrolizumab on Laryngeal Cancer Cells via the p53 Pathway

Figure 4

Hsa-miR-128a targeted BMI-1, as shown by Western blot analysis of BMI-1 protein after immunoprecipitation-mediated enrichment in laryngeal AMC-HN8 cells transfected with hsa-miR-128a mimics or control for 48 hours. The exogenous expression of hsa-miR-128a strongly reduced the amount of immunoprecipitated BMI-1 protein in AMC-HN8 cells.